These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1733892)

  • 1. Hereditary ovarian cancer: a dilemma in prognosis.
    Klein B; Lurie H; Stein M; Kuten A; Steinherz R
    Isr J Med Sci; 1992 Jan; 28(1):16-9. PubMed ID: 1733892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and management strategies of hereditary ovarian cancer syndrome].
    Shen K; Lang J; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):732-5. PubMed ID: 9387515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prophylactic oophorectomy in cancer prevention.
    Averette HE; Nguyen HN
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
    Geary M; Geoghegan A; Foley M
    Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and management of patients at high genetic risk for ovarian carcinoma.
    Lynch HT; Albano WA; Lynch JF; Lynch PM; Campbell A
    Obstet Gynecol; 1982 May; 59(5):589-96. PubMed ID: 7070730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary ovarian cancer.
    Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report.
    Rose PG; Hunter RE
    J Reprod Med; 1994 Nov; 39(11):908-10. PubMed ID: 7853284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
    Swisher EM; Babb S; Whelan A; Mutch DG; Rader JS
    J Reprod Med; 2001 Feb; 46(2):87-94. PubMed ID: 11255821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome.
    Lynch HT; Severin MJ; Mooney MJ; Lynch J
    Gynecol Oncol; 1995 Apr; 57(1):23-6. PubMed ID: 7705697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
    Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
    Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial ovarian cancer syndrome].
    Bösze P
    Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK
    J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian conservation at the time of hysterectomy for benign disease.
    Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
    Clin Obstet Gynecol; 2007 Jun; 50(2):354-61. PubMed ID: 17513923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.